Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Andexxa

Biological Hematology/Neurology

NDC 69853-0101-1

Open in the dashboard

General payments

$2,526,663

12,581 payments

Research payments

$1,124,400

966 payments

Through program year 2020, $2,526,663 in general payments and $1,124,400 in research payments were reported against Andexxa (Hematology/Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $1,228,613 3,397
2020 Research $724,791 243
2019 General $1,298,049 9,184
2019 Research $399,609 723

Breakdown

Who paid General payments · program years 2019–2020
  1. Portola Pharmaceuticals, Inc. $2,526,663 12,581 payments
Top recipients General payments · program year 2020
  1. Hartford Hospital Teaching hospital · CT $132,500 11% · 2 payments
  2. Charles Homcy Geyserville, CA $129,000 10% · 8 payments
  3. Fariborz Rezai Critical Care Medicine · Livingston, NJ $77,973 6% · 78 payments
  4. Melissa Taylor Emergency Medical Services · Grand Rapids, MI $43,646 4% · 59 payments
  5. David Burt Emergency Medicine · Charlottesville, VA $42,292 3% · 48 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Emergency Medicine $265,184 30% · 408 practitioners
  2. Neurology Psychiatry & Neurology $111,008 12% · 176 practitioners
  3. Critical Care Medicine Internal Medicine $97,811 11% · 80 practitioners
  4. Emergency Medical Services Emergency Medicine $53,511 6% · 17 practitioners
  5. Rheumatology Internal Medicine $40,588 5% · 4 practitioners

The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $282,025 23% · 182 recipients
  2. Connecticut $133,974 11% · 46 recipients
  3. New Jersey $128,901 10% · 128 recipients
  4. Florida $110,555 9% · 269 recipients
  5. Texas $97,075 8% · 168 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

12,581 general · 966 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record